ARCHIVES

Get the latest industry insights.

Quality people. Great service. Responsive. Professional.

Day: November 20, 2019

FDA approves first targeted therapy to treat patients with painful complication of sickle cell disease

FDA Approves First Targeted Therapy to Treat Patients with Painful Complication of Sickle Cell Disease

VIA: https://www.worldpharmanews.com/fda/5020-fda-approves-first-targeted-therapy-to-treat-patients-with-painful-complication-of-sickle-cell-disease Today, the U.S. Food and Drug Administration approved Adakveo (crizanlizumab-tmca), a treatment to reduce the frequency of vaso-occlusive crisis – a common and painful complication of sickle cell disease that occurs when blood

Read More »